Last reviewed · How we verify

Std-dose iv MgSO4 — Competitive Intelligence Brief

Std-dose iv MgSO4 (Std-dose iv MgSO4) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant, Vasodilator. Area: Cardiovascular, Neurology.

phase 3 Anticonvulsant, Vasodilator Voltage-gated calcium channels Cardiovascular, Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Std-dose iv MgSO4 (Std-dose iv MgSO4) — Hamad Medical Corporation. Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Std-dose iv MgSO4 TARGET Std-dose iv MgSO4 Hamad Medical Corporation phase 3 Anticonvulsant, Vasodilator Voltage-gated calcium channels
Losartan/amlodipine or losartan/hydrochlorothiazide Losartan/amlodipine or losartan/hydrochlorothiazide Yokohama City University Medical Center marketed Angiotensin II receptor blocker combination (ARB + calcium channel blocker or ARB + thiazide diuretic) Angiotensin II type 1 receptor (AT1R); L-type voltage-gated calcium channels (amlodipine) or sodium-chloride cotransporter (hydrochlorothiazide)
Lyrica (pregabalin) Lyrica (pregabalin) Pfizer's Upjohn has merged with Mylan to form Viatris Inc. marketed Gabapentinoid; anticonvulsant; anxiolytic Alpha-2-delta subunit of voltage-gated calcium channels
Pregabalin 25 MG Pregabalin 25 MG Ajou University School of Medicine marketed Anticonvulsant α2δ subunit of voltage-gated calcium channels
gabapentin + tramadol gabapentin + tramadol Southwest Hospital, China marketed Analgesic combination (anticonvulsant + opioid) Voltage-gated calcium channels (Cav2.1, Cav2.2); μ-opioid receptor; serotonin and norepinephrine transporters
Lercanidipine/enalapril fixed combination Lercanidipine/enalapril fixed combination Meir Medical Center marketed Calcium channel blocker / ACE inhibitor combination L-type voltage-gated calcium channels; Angiotensin-converting enzyme (ACE)
Standard dose gabapentin Standard dose gabapentin Mario Negri Institute for Pharmacological Research marketed Anticonvulsant; gabapentinoid Alpha-2-delta-1 subunit of voltage-gated calcium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant, Vasodilator class)

  1. Hamad Medical Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Std-dose iv MgSO4 — Competitive Intelligence Brief. https://druglandscape.com/ci/std-dose-iv-mgso4. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: